APP and early-onset autosomal dominant Alzheimer disease: These findings suggest that higher levels of APP, whether it be higher levels of the beta‐amyloid peptide, the extracellular or cytoplasmic fragments, and/or full‐length APP, are correlated with early‐onset Alzheimer's disease.